P - Contraindicated in pregnancy
L - Cautioned in lactation
Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pressure). This effect is thought to be caused by reducing the production of the liquid (which is called the aqueous humor) within the eye. The precise mechanism of this effect is not known. The reduction in intraocular pressure reduces the risk of damage to the optic nerve and loss of vision in patients with elevated intraocular pressure due to glaucoma.
Information Not Available
Information Not Available
Topical use in eye: Mild ocular stinging & discomfort, usually transient & well – tolerated. Rarely, decreased corneal sensitivity erthyema, itching, keratitia & photophobia reported; tiredness, fatigue, headache, impotance, sleep disturbances, cold hands & feet, GI upsets, Bradycardia esp in elderly.
Information Not Available
Poor cardiac reserve, bronchospastic diseases, Dm, renal or hepatic impairment. May mask sings of hyperthyroidism. Gradual withdrawal is recommended.
May cause mydriasis when use concurrently wth epinephrine. Close observation needed when on β- blocker & catecholomine- depleting drugs such as resperpine, due to possible additive effects resulting in hypotension and or bradycardia. Caution when used concomitantly with adrenergic, psychotropic drugs. Enhances Cn channels blockers, anaesthetics & clonidine.
Information Not Available
Ophthalmic
Open – angle glaucoma & ocular hypertension: Adult; instil one drop of 0.25% or 0.5% solution bid.
Oral
Angina Pectoris
Hypertension; Adult: Initially, 10-20 mg once daily. May increase dose to 40mg/ day if necessary after 7- 14 days depending on the patient's response.
Elderly: Initial Dose of 5-10mg/day.
Information Not Available
Contraindicated in pregnancy
Cautioned in lactation
Information Not Available
Information Not Available
Sinus bradycardia, cardiogenic shock, overt cardiac failure. Pregnancy.
Information Not Available
Information Not Available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.